Investigations into the mechanisms underlying TMAO-induced MCI suggest that elevated TMAO levels may initiate inflammatory cascades, particularly through the activation of the NF-kB pathway, which heightens the risk of neuroinflammation when the integrity of the blood–brain barrier is compromised, ultimately contributing to cognitive decline (33–35). This evidence concerns the gene NFKB1 and Mental deterioration.